Julian Baker
Chairman presso MADRIGAL PHARMACEUTICALS, INC.
Patrimonio netto: 22 M $ in data 31/03/2024
Profilo
Julian Charles Baker is the founder and the Managing Partner of Baker Bros.
Advisors LP, which was founded in 2000.
He is currently the Independent Chairman at Madrigal Pharmaceuticals, Inc. since 2023, Lead Independent Director at Incyte Corp.
since 2001, Independent Director at ACADIA Pharmaceuticals, Inc. since 2015, Independent Director at Prelude Therapeutics, Inc. since 2021, Director at EveryONE Medicines, Inc., Director at Alumis, Inc., Managing Member at Baker Bros.
Advisors GP LLC, and Partner at FBB Associates.
Mr. Baker has held former positions as Director at Neurogen Corp.
from 1999 to 2009, Independent Director at Idera Pharmaceuticals, Inc. from 2014 to 2018, Director at Trimeris, Inc. from 2004 to 2011, Lead Independent Director at Genomic Health, Inc. from 2001 to 2019, Director at Innoviva, Inc. from 1999 to 2007, Director at Presidio Pharmaceuticals, Inc., Member at Credit Suisse First Boston Corp.
from 1988 to 1993, Principal at CSFB Private Equity Partners LLC, Advisory Board Member at Elm Street Advisors LLC, and Portfolio Manager at Tisch Financial Management from 1994 to 1999.
Mr. Baker obtained his undergraduate degree from Harvard University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INCYTE CORPORATION
0.12% | 28/03/2024 | 278 773 ( 0.12% ) | 16 M $ | 31/03/2024 |
BEIGENE LTD
0.03% | 14/11/2023 | 311 143 ( 0.03% ) | 4 M $ | 31/03/2024 |
| 22/05/2023 | 102 876 ( 0.06% ) | 2 M $ | 31/03/2024 | |
CERUS CORPORATION
0.01% | 31/12/2023 | 19 864 ( 0.01% ) | 37 543 $ | 31/03/2024 |
Posizioni attive di Julian Baker
| Società | Posizione | Inizio |
|---|---|---|
| INCYTE CORPORATION | Director/Board Member | 01/01/2001 |
| ACADIA PHARMACEUTICALS INC. | Director/Board Member | 11/12/2015 |
| PRELUDE THERAPEUTICS INCORPORATED | Director/Board Member | 25/01/2021 |
| MADRIGAL PHARMACEUTICALS, INC. | Chairman | 15/06/2023 |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Founder | 01/01/2000 |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Director/Board Member | - |
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | Director/Board Member | - |
| FBB Associates | Corporate Officer/Principal | - |
| Baker Bros. Advisors GP LLC | Corporate Officer/Principal | - |
Precedenti posizioni note di Julian Baker
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Julian Baker
| Harvard University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 14 |
|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Finance |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
| Baker Bros. Advisors GP LLC | |
| FBB Associates | |
| Credit Suisse First Boston Corp. | Finance |
CSFB Private Equity Partners LLC
 CSFB Private Equity Partners LLC Investment ManagersFinance CSFB Private Equity Partners LLC (CSFB Private Equity) is a private equity subsidiary of Credit Suisse Private Equity LLC founded in 1988. The firm is headquartered in New York. | Finance |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
Elm Street Advisors LLC
 Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut. | Finance |
| Tisch Financial Management | |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | Commercial Services |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Julian Baker
